The Global Transcatheter Pulmonary Valve Market is expected to grow from USD 41.59 Million in 2018 to USD 76.94 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.18%. Read the fu
Dublin, April 28, 2020 -- The "Autotransfusion Devices Market to 2027 - Global Analysis and Forecasts by Type; Application; End User; and Geography" report has been added.
LivaNova PLC (NASDAQ : LIVN), une société mondiale de technologie médicale et d’innovation leader sur le marché, a annoncé aujourd’hui que sa canule B
LivaNova PLC (NASDAQ:LIVN), ein marktführendes Unternehmen für Medizintechnik und Innovationen, gab heute bekannt, dass seine Bi-Flow-Kanüle für extra
LivaNova PLC (NASDAQ: LIVN), een marktleider op het gebied van medische technologie en innovatie, kondigde vandaag zijn Bi-Flow Extracorporale Membran
LivaNova PLC (NASDAQ:LIVN), società leader del settore quanto a innovazione e tecnologie mediche, ha annunciato in data odierna di aver ottenuto l'aut
LivaNova PLC announced its Bi-Flow ECMO earned CE Mark for ECMO procedures where femoral artery cannulation can be applied.
First Hawaiian Bank boosted its stake in LivaNova PLC (NASDAQ:LIVN) by 24.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutio
Pune, April 27, 2020 -- The global Transcatheter Heart Valve Replacement Market size is anticipated to reach USD 10.34 billion by 2026 on account of the increasing number of.
Wall Street analysts expect LivaNova PLC (NASDAQ:LIVN) to announce $234.77 million in sales for the current fiscal quarter, Zacks reports. Three analysts have made estimates for LivaNova’s earnings,
LivaNova (NASDAQ:LIVN) was upgraded by equities researchers at BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Saturday, BidAskClub reports. Several other res
Shares of LivaNova PLC (NASDAQ:LIVN) have been given a consensus recommendation of “Hold” by the nine analysts that are covering the company, Marketbeat Ratings reports. Two research analysts have
LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE